Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.
about
Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamilyResponse rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathwaysFollowing a TRAIL: update on a ligand and its five receptorsFLIP and the death effector domain familyTRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitroSelective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells.Effect of hyperthermia in combination with TRAIL on the JNK-Bim signal transduction pathway and growth of xenograft tumors.Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formationDeath receptor 5 expression is inversely correlated with prostate cancer progression.The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase RRapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants.The role of TRADD in TRAIL-induced apoptosis and signaling.B lymphocytes are resistant to death receptor 5-induced apoptosis.P45 forms a complex with FADD and promotes neuronal cell survival following spinal cord injury.Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase.TRAIL Is Decreased Before 20 Weeks Gestation in Women with Hypertensive Disorders of Pregnancy.Caspase-containing complexes in the regulation of cell death and inflammation.Apoptosis and autophagy: regulatory connections between two supposedly different processes.Autophagy regulates selective HMGB1 release in tumor cells that are destined to die.Molecular dynamics simulations of protein dynamics and their relevance to drug discovery.Combined modality therapy with TRAIL or agonistic death receptor antibodies.Six1: a critical transcription factor in tumorigenesis.Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway.Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.Role of Bax in quercetin-induced apoptosis in human prostate cancer cells.Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding.Evidence for two modes of development of acquired tumor necrosis factor-related apoptosis-inducing ligand resistance. Involvement of Bcl-xL.FADD self-association is required for stable interaction with an activated death receptor.A mechanism for death receptor discrimination by death adaptors.Role of the receptor-mediated apoptosis in Helicobacter pylori in gastric epithelial cells.The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.Fibroblast apoptosis induced by Porphyromonas gingivalis is stimulated by a gingipain and caspase-independent pathway that involves apoptosis-inducing factor.Synthetic ligands of death receptor 5 display a cell-selective agonistic effect at different oligomerization levels.A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.Natural Products for the Management and Prevention of Breast Cancer.The regulation of cytokine signaling by retinal determination gene network pathway in cancer
P2860
Q24654366-F475B4A2-741C-4F72-B844-2421883C8FA7Q24810525-D58C5AB5-5944-40E8-9959-28F9A9A75778Q28292767-96F6143F-6AF4-44C0-95F0-B243BBC57CA5Q28297969-126058D1-4BC5-4F4A-B3F3-53E029F57F49Q33802751-D782426D-F270-48EF-982C-B98821E67CE8Q33913756-2761A26F-DDC9-4C7D-93EC-1C29B7BE46DDQ34257806-1D5A96D3-C1B2-46A3-BD00-F65284D47782Q34334395-7E49279B-721B-4E8B-B707-869B1C72B849Q34426868-F9DE673D-D772-4E85-8DB0-EA46915755CBQ34529862-926F4515-D36F-413F-AA60-1CDD9F7E52D2Q34561798-36085B94-8355-4618-B5BE-581A03AF0CE0Q34682495-88DEAE27-FB9F-4D1D-AC0B-D8FF073AE2E7Q34728945-2DBDA787-CD5E-48DC-8C70-274AE39E2030Q34919673-D7616A9C-09E9-47AF-91E1-F5483BB572D8Q35092846-2FC41461-A8B6-439F-8D4E-2401C0D183BEQ35647963-D33924E6-D61F-45F7-87EB-51309DA1162AQ36559701-F3685ECF-D4D3-4A70-9D92-A2793288A5B6Q36996255-21EFC0C6-88D9-4FEC-BB40-460239043997Q37019453-480C4FE0-F273-4556-BC49-1C7B13F348A3Q37802710-30F9BF9E-3049-459D-9A15-ABD9DD1A3C2AQ37832083-2DA4B751-633F-416F-BCA4-398C81EC094DQ38184513-BC112DDC-3DC0-4CEB-A1E6-EE25AB35F6DCQ39226135-72994C0C-17FA-44DB-8CBF-044D9625E12DQ39634949-31D8CE2C-912F-416D-888D-E169C23A59E4Q39985533-BDB41CD8-0090-41B2-BE6A-349796E790AFQ40100090-0BBB8C48-9CEC-4B52-82D0-F11FF1C17286Q40207500-6C6A888B-8497-4AD6-8A93-34ABE71BDC50Q40277983-2A563316-781E-47D3-9228-BE6FA2F530F6Q40399767-2979E2D2-B8AF-4A73-BBCE-3A8239E7B69BQ40489065-0D104F3F-7F9D-4729-96E8-4897C2081DB8Q40510248-3AF88699-1EAC-492B-90A0-B339F722B4E6Q41075237-DB9FBDA0-EA10-4F27-A824-309EC1F2AF0CQ41778655-48D93FFA-C897-4759-8532-6DC6CA50BC89Q44236067-EE3B47E0-D62E-4CD5-9AA8-1459AF8A8C6FQ55043805-C3A4F12B-BAEA-4034-9AA0-A977CD4B3979Q57483942-F2974324-8F40-42D0-AFEC-CC97ABA9A9F5
P2860
Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Direct binding of Fas-associat ...... death effector domain of FADD.
@ast
Direct binding of Fas-associat ...... death effector domain of FADD.
@en
Direct binding of Fas-associated death domain
@nl
type
label
Direct binding of Fas-associat ...... death effector domain of FADD.
@ast
Direct binding of Fas-associat ...... death effector domain of FADD.
@en
Direct binding of Fas-associated death domain
@nl
prefLabel
Direct binding of Fas-associat ...... death effector domain of FADD.
@ast
Direct binding of Fas-associat ...... death effector domain of FADD.
@en
Direct binding of Fas-associated death domain
@nl
P2093
P2860
P356
P1476
Direct binding of Fas-associat ...... death effector domain of FADD
@en
P2093
Adrianna Henson
Andrew Thorburn
John C Reed
Lance R Thomas
P2860
P304
32780-32785
P356
10.1074/JBC.M401680200
P407
P577
2004-06-01T00:00:00Z